L
Lou F. M. H. de Leij
Researcher at University of Groningen
Publications - 73
Citations - 3621
Lou F. M. H. de Leij is an academic researcher from University of Groningen. The author has contributed to research in topics: Antigen & Monoclonal antibody. The author has an hindex of 34, co-authored 73 publications receiving 3503 citations. Previous affiliations of Lou F. M. H. de Leij include University Medical Center Groningen.
Papers
More filters
Journal ArticleDOI
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer
Klaas Kok,Jan Osinga,B. Carritt,Mary B. Davis,Annemarie H. van der Hout,Anneke Y. van der Veen,R.M. Landsvater,Lou F. M. H. de Leij,Henk H. Berendsen,Pieter E. Postmus,Sibrand Poppema,Charles H.C.M. Buys +11 more
TL;DR: Evidence is presented for a consistent deletion at the chromosomal region 3p21, not only in SCLC11, but in all major types of lung cancer.
Journal ArticleDOI
EpCAM in carcinogenesis: the good, the bad or the ugly
Bernardina T. F. van der Gun,Lieuwe J. Melchers,Marcel H. J. Ruiters,Lou F. M. H. de Leij,Pamela M.J. McLaughlin,Marianne G. Rots +5 more
TL;DR: The controversial biological role of EpCAM is described with the focus on carcinogenesis: as an adhesion molecule, EpCam mediates homophilic adhesion interactions, which in turn might prevent metastasis, and epigenetic editing is proposed as a novel approach to investigate the biological role.
Journal ArticleDOI
In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
TL;DR: This review gives a concise overview of studies on the application of cationic liposomes in vivo in animal models of diseases and in clinical studies, and discusses the transfection efficiency, the pharmacokinetic and pharmacodynamic properties of the lipid-DNA complexes, and potentially relevant applications for cationo- DNA complexes.
Journal ArticleDOI
CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences
W.J Tamminga,Johan Wemer,B. Oosterhuis,Jaap Wieling,Bob Wilffert,Lou F. M. H. de Leij,R.A. de Zeeuw,Jan H.G. Jonkman +7 more
TL;DR: In EM females compared to EM males, CYP2D6 activity is increased and CyP2C19 activity is reduced, and this reduction is substantial and most pronounced in the age range from 18 to 40 years.
Journal ArticleDOI
Targeted induction of apoptosis for cancer therapy: current progress and prospects
TL;DR: Recent progress and prospects of selected novel anti-cancer approaches that specifically target and sensitize cancer cells to apoptosis are reviewed.